data_1znt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1znt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.528 0.68 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.11 0.481 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 110.963 -0.014 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' ARG . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 110.972 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 . . . . . 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 4.2 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.277 0.561 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 C--O 1.228 -0.039 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 111.362 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 . . . . . 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' HA ' ' OE2' ' A' ' 3' ' ' GLU . 10.8 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.42 20.8 31.22 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.625 0.631 . . . . 0.0 112.541 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' OE2' ' HA ' ' A' ' 1' ' ' VAL . 1.3 pm0 -89.94 131.92 35.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -82.02 -12.02 58.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.08 52.01 40.29 Favored Glycine 0 N--CA 1.447 -0.587 0 O-C-N 120.477 -1.39 . . . . 0.0 112.019 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.04 156.11 46.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t -123.82 4.57 8.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.24 89.25 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.18 -0.95 . . . . 0.0 112.686 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.63 179.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 130.389 3.476 . . . . 0.0 107.346 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 119.393 0.997 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 13.2 45.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.114 0.864 . . . . 0.0 112.858 -173.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -77.46 148.63 35.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.956 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 mp0 -74.49 -7.09 51.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.28 79.15 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.636 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p -120.18 158.06 27.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t -105.27 -47.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.28 -41.41 11.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 53.96 -10.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 130.741 3.617 . . . . 0.0 119.035 158.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 120.903 1.683 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.418 ' HA ' ' OE2' ' A' ' 3' ' ' GLU . 7.0 p . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.29 7.75 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 113.507 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' OE2' ' HA ' ' A' ' 1' ' ' VAL . 0.7 OUTLIER -97.9 146.12 25.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.771 2.029 . . . . 0.0 110.123 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.93 -2.95 26.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.21 15.56 67.84 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.043 -1.036 . . . . 0.0 112.181 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -96.27 114.32 26.0 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.463 0.705 . . . . 0.0 112.603 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -97.88 -35.66 10.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.26 -25.75 6.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 123.55 0.595 . . . . 0.0 113.367 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 69.26 -51.85 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.476 2.711 . . . . 0.0 113.341 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 117.951 0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.17 -33.97 0.65 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.502 1.046 . . . . 0.0 114.116 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.22 154.15 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.256 1.822 . . . . 0.0 112.93 162.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.02 -14.52 36.42 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 16.07 81.0 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.247 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m -102.51 149.91 23.92 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t -100.71 -45.07 5.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 -16.14 36.45 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.527 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.73 -55.82 0.42 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.749 2.42 . . . . 0.0 113.422 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 118.571 0.623 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 11.4 m . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -64.85 2.15 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -165.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -80.52 163.02 24.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.029 0.932 . . . . 0.0 110.963 159.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -64.05 0.07 1.02 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 14.6 65.84 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.618 -0.676 . . . . 0.0 112.869 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.38 152.18 51.18 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -168.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.23 -56.11 2.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.84 -4.36 60.35 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 114.116 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -50.29 0.68 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.241 2.216 . . . . 0.0 112.966 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.008 0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.32 87.03 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.287 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -45.1 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.574 1.687 . . . . 0.0 113.359 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.33 -3.47 46.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.78 50.76 4.53 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.369 1.461 . . . . 0.0 112.297 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p -117.72 165.28 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -169.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.51 -42.7 22.03 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.21 -22.61 37.35 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.713 1.149 . . . . 0.0 112.742 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.345 0.0 OUTLIER 58.53 -43.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.741 3.617 . . . . 0.0 116.251 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 119.367 0.985 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.75 14.12 7.55 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.272 0.939 . . . . 0.0 114.522 167.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 -66.77 155.49 38.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.504 1.521 . . . . 0.0 112.861 -168.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.03 -18.27 27.67 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.97 8.47 64.91 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 118.83 -0.983 . . . . 0.0 115.37 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m -102.27 155.39 18.26 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.79 -79.15 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.88 -14.29 80.2 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.868 0.758 . . . . 0.0 114.733 -172.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.256 9.7 ptp180 51.75 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 132.234 4.214 . . . . 0.0 120.032 169.896 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 120.962 1.71 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.61 71.76 1.04 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -160.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -92.5 151.26 20.28 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.056 -0.673 . . . . 0.0 110.996 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 6' ' ' ARG . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.416 ' H ' ' C ' ' A' ' 4' ' ' CYS 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -64.0 -7.38 8.35 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.25 8.57 74.67 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.858 1.694 . . . . 0.0 114.131 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -109.44 144.78 37.2 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.043 0.937 . . . . 0.0 113.215 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -96.4 -25.89 15.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.34 -0.95 10.31 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.893 1.235 . . . . 0.0 113.187 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 68.91 -51.49 0.58 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 128.652 2.781 . . . . 0.0 113.834 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.435 0.561 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.86 -48.13 0.97 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -154.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -70.12 167.01 18.65 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 139.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.08 -9.78 0.98 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.98 -33.17 0.91 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 120.619 -1.301 . . . . 0.0 114.134 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p -135.89 159.56 41.29 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -167.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -123.0 -8.48 8.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.95 60.53 2.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 158.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -65.44 -31.56 72.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -145.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 O-C-N 121.758 -0.589 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.32 58.93 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.428 0.537 . . . . 0.0 113.283 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -61.21 121.56 12.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.27 1.428 . . . . 0.0 110.841 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.428 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -68.47 -12.29 61.0 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.33 15.61 56.93 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 117.894 -1.503 . . . . 0.0 114.657 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.82 145.08 26.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.428 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t -83.15 62.77 6.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.15 -68.01 0.21 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.099 1.809 . . . . 0.0 110.927 -172.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 -0.48 0.53 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 113.596 170.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 O-C-N 119.995 -1.69 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.84 4.41 31.71 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.619 1.104 . . . . 0.0 113.498 -172.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.8 OUTLIER -77.03 149.14 35.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.294 1.838 . . . . 0.0 110.972 174.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.402 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 -59.9 -1.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.86 -31.78 1.73 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.384 -1.448 . . . . 0.0 115.006 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 158.7 19.05 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.237 -0.914 . . . . 0.0 112.465 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.69 0.24 4.37 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.86 -20.02 54.65 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 153.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' NH2' ' HA ' ' A' ' 16' ' ' SER . 2.6 tpm_? 73.31 -37.62 0.39 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.067 2.947 . . . . 0.0 115.519 160.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 118.823 0.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.52 -69.82 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.73 164.81 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.854 2.861 . . . . 0.0 116.901 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -70.05 -1.92 11.29 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.51 79.01 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.739 -1.034 . . . . 0.0 114.609 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -120.49 149.03 43.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.402 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 4.2 t -85.22 65.57 9.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 -70.64 0.56 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.59 5.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 158.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.385 0 O-C-N 119.997 -1.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.41 22.5 4.07 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.844 1.211 . . . . 0.0 113.541 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -80.02 167.56 20.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.039 1.736 . . . . 0.0 112.206 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -64.1 -14.15 52.66 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.73 7.33 63.07 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.846 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.58 142.42 39.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.345 1.458 . . . . 0.0 112.872 -171.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -101.21 -52.3 3.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.77 -5.05 56.76 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.901 0.763 . . . . 0.0 114.195 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.67 -50.94 0.67 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.428 2.291 . . . . 0.0 113.1 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.486 0 O-C-N 121.924 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.53 -71.75 1.04 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -168.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 38.86 169.64 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 131.377 3.871 . . . . 0.0 118.024 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -56.52 -13.71 2.55 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.5 12.38 82.34 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.607 -0.683 . . . . 0.0 112.282 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p -139.52 166.16 25.32 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.624 -0.673 . . . . 0.0 112.758 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -79.02 -16.23 57.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.19 17.43 9.81 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.899 1.238 . . . . 0.0 110.841 163.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 tpt85 60.68 -23.72 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.128 2.571 . . . . 0.0 116.662 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 119.859 -1.776 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . 0.453 ' HO3' ' C1 ' ' A' ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . 0.453 ' C1 ' ' HO3' ' A' ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.06 -46.39 1.07 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 -159.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -63.54 149.32 46.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 139.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -11.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.16 75.15 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.954 0.797 . . . . 0.0 111.522 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.65 160.53 37.26 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.77 -19.39 65.1 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.23 25.31 4.34 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.277 0.941 . . . . 0.0 111.053 167.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 41.95 29.04 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.855 2.062 . . . . 0.0 115.108 -168.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 O-C-N 120.758 -1.214 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.415 ' HA ' ' OE2' ' A' ' 3' ' ' GLU . 17.2 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.528 -0.272 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.78 34.62 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.701 0.667 . . . . 0.0 112.288 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.419 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.7 pm0 -80.53 146.23 31.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.328 1.451 . . . . 0.0 111.362 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -2.58 3.61 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.99 59.7 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.713 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -95.11 127.67 41.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.438 0.695 . . . . 0.0 111.239 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.73 -36.58 17.27 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -32.88 58.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.3 -27.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 130.147 3.379 . . . . 0.0 116.526 163.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 119.948 1.249 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.65 12.49 11.51 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.128 1.823 . . . . 0.0 114.138 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -68.02 111.22 4.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.226 2.61 . . . . 0.0 111.0 -166.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -85.66 5.66 30.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.64 11.21 31.34 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.656 -1.08 . . . . 0.0 115.389 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -87.46 139.36 30.62 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.907 -1.121 . . . . 0.0 112.723 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -83.68 63.04 7.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.04 -27.54 1.15 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.603 1.573 . . . . 0.0 114.381 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 73.92 -48.07 0.66 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 128.913 2.885 . . . . 0.0 112.211 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.12 45.17 1.11 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.327 0.965 . . . . 0.0 111.511 -169.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 150.68 29.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 -158.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -72.59 -13.61 61.43 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.54 30.77 57.76 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 120.721 -1.237 . . . . 0.0 112.663 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -107.7 147.53 30.62 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.36 10.06 29.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.29 37.92 94.83 Favored Glycine 0 CA--C 1.527 0.782 0 O-C-N 120.795 -1.191 . . . . 0.0 110.844 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -4.74 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.274 1.829 . . . . 0.0 114.342 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 O-C-N 119.929 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.528 0.68 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.11 0.481 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 4.6 mp0 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.418 ' SD ' ' HE2' ' A' ' 23' ' ' LYS . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 110.963 -0.014 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 21' ' ' CYS . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 31.9 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' CG ' ' A' ' 6' ' ' ARG 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 . . . . . 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.277 0.561 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 C--O 1.228 -0.039 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 . . . . . 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.42 20.8 31.22 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.625 0.631 . . . . 0.0 112.541 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.3 pm0 -89.94 131.92 35.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -82.02 -12.02 58.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.08 52.01 40.29 Favored Glycine 0 N--CA 1.447 -0.587 0 O-C-N 120.477 -1.39 . . . . 0.0 112.019 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.04 156.11 46.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t -123.82 4.57 8.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.24 89.25 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.18 -0.95 . . . . 0.0 112.686 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.63 179.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 130.389 3.476 . . . . 0.0 107.346 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 119.393 0.997 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.403 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 13.2 45.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.114 0.864 . . . . 0.0 112.858 -173.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -77.46 148.63 35.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.956 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 4.6 mp0 -74.49 -7.09 51.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.28 79.15 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.636 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p -120.18 158.06 27.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t -105.27 -47.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.28 -41.41 11.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 53.96 -10.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 130.741 3.617 . . . . 0.0 119.035 158.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 120.903 1.683 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.29 7.75 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 113.507 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.7 OUTLIER -97.9 146.12 25.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.771 2.029 . . . . 0.0 110.123 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.93 -2.95 26.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.21 15.56 67.84 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.043 -1.036 . . . . 0.0 112.181 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -96.27 114.32 26.0 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.463 0.705 . . . . 0.0 112.603 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -97.88 -35.66 10.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.26 -25.75 6.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 123.55 0.595 . . . . 0.0 113.367 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 69.26 -51.85 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.476 2.711 . . . . 0.0 113.341 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 117.951 0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.17 -33.97 0.65 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.502 1.046 . . . . 0.0 114.116 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.22 154.15 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.256 1.822 . . . . 0.0 112.93 162.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.418 ' SD ' ' HE2' ' A' ' 23' ' ' LYS . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.02 -14.52 36.42 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 16.07 81.0 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.247 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m -102.51 149.91 23.92 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t -100.71 -45.07 5.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 -16.14 36.45 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.527 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.73 -55.82 0.42 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.749 2.42 . . . . 0.0 113.422 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 118.571 0.623 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.527 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 11.4 m . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -64.85 2.15 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -165.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -80.52 163.02 24.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.029 0.932 . . . . 0.0 110.963 159.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -64.05 0.07 1.02 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 14.6 65.84 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.618 -0.676 . . . . 0.0 112.869 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.38 152.18 51.18 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -168.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.23 -56.11 2.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.84 -4.36 60.35 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 114.116 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -50.29 0.68 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.241 2.216 . . . . 0.0 112.966 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.008 0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.32 87.03 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.287 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -45.1 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.574 1.687 . . . . 0.0 113.359 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 21' ' ' CYS . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.33 -3.47 46.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PFF . . . . . 0.425 ' HB3' ' CD2' ' A' ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.78 50.76 4.53 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.369 1.461 . . . . 0.0 112.297 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PFF . . . . . 0.425 ' CD2' ' HB3' ' A' ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 31.9 p -117.72 165.28 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -169.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.51 -42.7 22.03 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.21 -22.61 37.35 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.713 1.149 . . . . 0.0 112.742 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.345 0.0 OUTLIER 58.53 -43.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.741 3.617 . . . . 0.0 116.251 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 119.367 0.985 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.424 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 15.7 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.75 14.12 7.55 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.272 0.939 . . . . 0.0 114.522 167.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 1' ' ' VAL . 56.8 mp0 -66.77 155.49 38.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.504 1.521 . . . . 0.0 112.861 -168.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.03 -18.27 27.67 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.97 8.47 64.91 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 118.83 -0.983 . . . . 0.0 115.37 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m -102.27 155.39 18.26 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.492 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.79 -79.15 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.88 -14.29 80.2 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.868 0.758 . . . . 0.0 114.733 -172.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.256 9.7 ptp180 51.75 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 132.234 4.214 . . . . 0.0 120.032 169.896 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 120.962 1.71 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.492 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.61 71.76 1.04 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -160.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -92.5 151.26 20.28 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.056 -0.673 . . . . 0.0 110.996 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' CG ' ' A' ' 6' ' ' ARG 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -64.0 -7.38 8.35 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.25 8.57 74.67 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.858 1.694 . . . . 0.0 114.131 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -109.44 144.78 37.2 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.043 0.937 . . . . 0.0 113.215 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CE2' ' H83' ' A' ' 34' ' ' NAG . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -96.4 -25.89 15.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.34 -0.95 10.31 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.893 1.235 . . . . 0.0 113.187 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 68.91 -51.49 0.58 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 128.652 2.781 . . . . 0.0 113.834 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.435 0.561 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.544 ' H83' ' CE2' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.86 -48.13 0.97 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -154.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -70.12 167.01 18.65 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 139.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.08 -9.78 0.98 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.98 -33.17 0.91 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 120.619 -1.301 . . . . 0.0 114.134 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p -135.89 159.56 41.29 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -167.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.504 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -123.0 -8.48 8.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.95 60.53 2.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 158.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -65.44 -31.56 72.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -145.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 O-C-N 121.758 -0.589 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.504 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.32 58.93 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.428 0.537 . . . . 0.0 113.283 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -61.21 121.56 12.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.27 1.428 . . . . 0.0 110.841 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -68.47 -12.29 61.0 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.33 15.61 56.93 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 117.894 -1.503 . . . . 0.0 114.657 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.82 145.08 26.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t -83.15 62.77 6.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.15 -68.01 0.21 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.099 1.809 . . . . 0.0 110.927 -172.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 -0.48 0.53 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 113.596 170.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 O-C-N 119.995 -1.69 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.84 4.41 31.71 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.619 1.104 . . . . 0.0 113.498 -172.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.8 OUTLIER -77.03 149.14 35.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.294 1.838 . . . . 0.0 110.972 174.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 -59.9 -1.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.86 -31.78 1.73 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.384 -1.448 . . . . 0.0 115.006 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PFF . . . . . 0.405 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 158.7 19.05 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.237 -0.914 . . . . 0.0 112.465 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.69 0.24 4.37 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.86 -20.02 54.65 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 153.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 16' ' ' SER . 2.6 tpm_? 73.31 -37.62 0.39 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.067 2.947 . . . . 0.0 115.519 160.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 118.823 0.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.476 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.52 -69.82 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.73 164.81 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.854 2.861 . . . . 0.0 116.901 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -70.05 -1.92 11.29 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.51 79.01 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.739 -1.034 . . . . 0.0 114.609 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -120.49 149.03 43.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.603 ' CE1' ' H83' ' A' ' 34' ' ' NAG . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 t -85.22 65.57 9.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 -70.64 0.56 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.59 5.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 158.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.385 0 O-C-N 119.997 -1.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.603 ' H83' ' CE1' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.41 22.5 4.07 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.844 1.211 . . . . 0.0 113.541 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -80.02 167.56 20.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.039 1.736 . . . . 0.0 112.206 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -64.1 -14.15 52.66 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.73 7.33 63.07 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.846 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.58 142.42 39.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.345 1.458 . . . . 0.0 112.872 -171.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -101.21 -52.3 3.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.77 -5.05 56.76 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.901 0.763 . . . . 0.0 114.195 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.67 -50.94 0.67 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.428 2.291 . . . . 0.0 113.1 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.486 0 O-C-N 121.924 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.53 -71.75 1.04 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -168.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 38.86 169.64 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 131.377 3.871 . . . . 0.0 118.024 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -56.52 -13.71 2.55 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.5 12.38 82.34 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.607 -0.683 . . . . 0.0 112.282 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p -139.52 166.16 25.32 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.624 -0.673 . . . . 0.0 112.758 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -79.02 -16.23 57.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.19 17.43 9.81 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.899 1.238 . . . . 0.0 110.841 163.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 tpt85 60.68 -23.72 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.128 2.571 . . . . 0.0 116.662 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 119.859 -1.776 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.06 -46.39 1.07 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 -159.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -63.54 149.32 46.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 139.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -11.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.16 75.15 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.954 0.797 . . . . 0.0 111.522 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.65 160.53 37.26 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.77 -19.39 65.1 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.23 25.31 4.34 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.277 0.941 . . . . 0.0 111.053 167.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 41.95 29.04 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.855 2.062 . . . . 0.0 115.108 -168.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 O-C-N 120.758 -1.214 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.528 -0.272 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.78 34.62 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.701 0.667 . . . . 0.0 112.288 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -80.53 146.23 31.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.328 1.451 . . . . 0.0 111.362 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -2.58 3.61 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.99 59.7 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.713 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -95.11 127.67 41.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.438 0.695 . . . . 0.0 111.239 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.811 ' CE1' ' H83' ' A' ' 34' ' ' NAG . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.73 -36.58 17.27 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -32.88 58.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.3 -27.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 130.147 3.379 . . . . 0.0 116.526 163.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 119.948 1.249 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.811 ' H83' ' CE1' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.65 12.49 11.51 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.128 1.823 . . . . 0.0 114.138 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -68.02 111.22 4.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.226 2.61 . . . . 0.0 111.0 -166.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -85.66 5.66 30.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.64 11.21 31.34 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.656 -1.08 . . . . 0.0 115.389 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -87.46 139.36 30.62 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.907 -1.121 . . . . 0.0 112.723 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -83.68 63.04 7.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.04 -27.54 1.15 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.603 1.573 . . . . 0.0 114.381 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 73.92 -48.07 0.66 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 128.913 2.885 . . . . 0.0 112.211 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.12 45.17 1.11 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.327 0.965 . . . . 0.0 111.511 -169.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 150.68 29.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 -158.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -72.59 -13.61 61.43 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.54 30.77 57.76 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 120.721 -1.237 . . . . 0.0 112.663 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -107.7 147.53 30.62 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' H81' ' A' ' 34' ' ' NAG . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.36 10.06 29.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.29 37.92 94.83 Favored Glycine 0 CA--C 1.527 0.782 0 O-C-N 120.795 -1.191 . . . . 0.0 110.844 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -4.74 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.274 1.829 . . . . 0.0 114.342 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 O-C-N 119.929 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 34' ' ' NAG . . . . . 0.49 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 CA--C 1.533 0.297 0 CA-C-O 121.528 0.68 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 . . . . . 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.533 0.318 0 CA-C-O 121.11 0.481 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 4.6 mp0 . . . . . 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.936 0.398 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m . . . . . 0 CA--C 1.528 0.109 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.418 ' SD ' ' HE2' ' A' ' 23' ' ' LYS . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 . . . . . 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 110.963 -0.014 . . . . 0.0 110.963 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 . . . . . 0 CA--C 1.54 0.571 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 21' ' ' CYS . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 31.9 p . . . . . 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.8 mp0 . . . . . 0 CA--C 1.538 0.492 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m . . . . . 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.53 0.205 0 CA-C-O 120.501 0.191 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' CG ' ' A' ' 6' ' ' ARG 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 . . . . . 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 . . . . . 0 CA--C 1.534 0.346 0 CA-C-O 120.851 0.358 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 . . . . . 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m . . . . . 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 121.142 0.496 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.188 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.545 0.77 0 N-CA-C 116.901 2.186 . . . . 0.0 116.901 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 . . . . . 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p . . . . . 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.277 0.561 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 CA--C 1.549 0.933 0 N-CA-C 118.024 2.602 . . . . 0.0 118.024 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p . . . . . 0 C--O 1.228 -0.039 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 . . . . . 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t . . . . . 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 CA--C 1.532 0.285 0 CA-C-O 121.35 0.595 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m . . . . . 0 CA--C 1.532 0.277 0 N-CA-C 111.239 0.089 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t . . . . . 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 . . . . . 0 CA--C 1.535 0.366 0 CA-C-O 120.676 0.274 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 . . . . . 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.467 0.392 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 . . . . . 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t . . . . . 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 p . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.42 20.8 31.22 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 123.625 0.631 . . . . 0.0 112.541 -174.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.3 pm0 -89.94 131.92 35.6 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.725 1.61 . . . . 0.0 111.192 -174.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.3 m -73.92 161.86 29.68 Favored 'General case' 0 C--O 1.239 0.505 0 O-C-N 121.259 -0.9 . . . . 0.0 111.45 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.3 56.96 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.475 1.11 . . . . 0.0 109.051 162.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? 48.48 35.59 6.13 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.929 2.492 . . . . 0.0 113.219 -177.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 162.27 -24.79 0.22 Allowed Glycine 0 CA--C 1.531 1.071 0 CA-C-N 114.458 -1.246 . . . . 0.0 115.557 171.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.96 167.18 21.7 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.192 1.496 . . . . 0.0 113.442 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -143.55 -179.42 0.95 Allowed Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 128.663 2.785 . . . . 0.0 107.843 179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -53.25 177.05 0.07 OUTLIER 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.673 2.915 . . . . 0.0 115.768 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.3 p -69.69 82.44 0.44 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.064 0.946 . . . . 0.0 113.148 -169.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 155.35 -19.12 0.53 Allowed Glycine 0 CA--C 1.528 0.884 0 CA-C-N 115.282 -0.872 . . . . 0.0 114.717 168.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -84.39 166.12 17.62 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 118.868 1.334 . . . . 0.0 112.134 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.5 m -119.94 162.95 18.32 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.466 1.506 . . . . 0.0 107.774 168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.2 t -120.12 149.86 41.54 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.669 0.668 . . . . 0.0 112.606 -168.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.5 p -108.26 -177.41 3.32 Favored 'General case' 0 N--CA 1.46 0.053 0 C-N-CA 125.275 1.43 . . . . 0.0 113.888 -168.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -82.02 -12.02 58.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.716 1.206 . . . . 0.0 112.011 -169.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.08 52.01 40.29 Favored Glycine 0 N--CA 1.447 -0.587 0 O-C-N 120.477 -1.39 . . . . 0.0 112.019 -169.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 31.9 p -132.04 156.11 46.86 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 -171.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.13 -165.37 37.57 Favored Glycine 0 CA--C 1.523 0.594 0 N-CA-C 109.706 -1.357 . . . . 0.0 109.706 -176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -128.95 32.54 4.74 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.335 0.654 . . . . 0.0 111.903 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.77 172.01 14.61 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.188 1.375 . . . . 0.0 112.035 175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -33.13 -72.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.475 1 C-N-CA 126.47 4.78 . . . . 0.0 115.769 -169.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.7 mtpt -73.42 -5.82 42.34 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.403 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 77.2 m-85 -89.51 -45.82 9.13 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 119.289 0.949 . . . . 0.0 111.368 174.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.4 t -123.82 4.57 8.78 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.08 6.24 89.25 Favored Glycine 0 CA--C 1.535 1.299 0 O-C-N 121.18 -0.95 . . . . 0.0 112.686 -167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 170.63 179.12 0.05 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 130.389 3.476 . . . . 0.0 107.346 -177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 119.393 0.997 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.403 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.52 13.2 45.35 Favored Glycine 0 CA--C 1.534 1.254 0 C-N-CA 124.114 0.864 . . . . 0.0 112.858 -173.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.4 pm0 -77.46 148.63 35.3 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.403 1.481 . . . . 0.0 110.956 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.0 m -82.18 142.94 31.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.358 1.075 . . . . 0.0 111.573 -173.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.3 t -72.29 78.11 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 125.107 1.363 . . . . 0.0 107.474 169.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 52.27 32.45 10.9 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.628 1.571 . . . . 0.0 112.6 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.58 -3.23 29.24 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.568 1.556 . . . . 0.0 114.804 -178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 3.8 mmp_? -114.9 177.88 4.49 Favored 'General case' 0 C--O 1.222 -0.344 0 CA-C-N 119.471 1.636 . . . . 0.0 112.312 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -175.16 177.01 0.62 Allowed Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 127.3 2.24 . . . . 0.0 106.058 -175.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.49 177.87 1.49 Allowed 'Trans proline' 0 CA--C 1.537 0.668 0 C-N-CA 122.428 2.086 . . . . 0.0 113.987 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.3 m -2.66 73.46 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 130.521 3.528 . . . . 0.0 117.031 -175.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.65 40.0 95.89 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 114.989 -1.005 . . . . 0.0 113.668 175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 67.0 mtt -78.05 167.31 21.64 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 119.268 1.534 . . . . 0.0 111.805 167.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.6 m -119.78 169.0 10.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.153 1.781 . . . . 0.0 109.072 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 36.3 t -127.08 138.2 53.16 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 123.736 0.815 . . . . 0.0 112.121 -170.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 p -86.72 -176.91 5.98 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 126.694 1.998 . . . . 0.0 113.654 -166.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.512 ' H ' ' CD ' ' A' ' 17' ' ' GLN . 4.6 mp0 -74.49 -7.09 51.9 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.711 174.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.63 17.28 79.15 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.024 -0.876 . . . . 0.0 113.636 176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.5 p -120.18 158.06 27.75 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -170.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.72 -177.25 44.61 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 176.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -101.65 0.65 36.55 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.589 0.959 . . . . 0.0 113.589 173.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -78.33 162.76 49.83 Favored Glycine 0 CA--C 1.534 1.22 0 O-C-N 122.184 -0.323 . . . . 0.0 112.306 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -44.01 -55.9 2.81 Favored 'Trans proline' 0 N--CA 1.459 -0.505 0 C-N-CA 124.437 3.424 . . . . 0.0 113.606 -175.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.8 mmmt -59.73 -21.6 60.89 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -95.88 -38.37 10.31 Favored 'General case' 0 CA--C 1.52 -0.192 0 C-N-CA 123.656 0.782 . . . . 0.0 110.78 -179.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.3 t -105.27 -47.22 4.02 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.28 -41.41 11.82 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.681 -0.967 . . . . 0.0 110.681 176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 53.96 -10.78 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 130.741 3.617 . . . . 0.0 119.035 158.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 120.903 1.683 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 115.32 15.29 7.75 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.624 1.107 . . . . 0.0 113.507 -169.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.7 OUTLIER -97.9 146.12 25.77 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 126.771 2.029 . . . . 0.0 110.123 179.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 86.2 m -65.74 156.07 34.17 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 123.337 1.542 . . . . 0.0 113.062 -169.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -83.34 59.93 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 127.897 2.479 . . . . 0.0 108.462 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.08 60.28 2.76 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.8 1.24 . . . . 0.0 108.497 -171.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.43 -1.97 82.56 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-N 114.768 -1.105 . . . . 0.0 115.799 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -118.16 164.44 15.15 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 119.455 1.628 . . . . 0.0 109.776 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.37 168.64 10.42 Favored Pre-proline 0 CA--C 1.538 0.516 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 172.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -83.34 -178.81 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.939 2.426 . . . . 0.0 111.594 -173.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.6 t 51.53 29.39 5.38 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.34 37.75 25.53 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.879 1.704 . . . . 0.0 112.827 -172.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -76.5 164.98 25.44 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.649 1.224 . . . . 0.0 110.575 173.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.0 m -118.14 154.36 32.28 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.525 1.13 . . . . 0.0 110.188 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.6 m -90.67 124.93 35.47 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.321 1.048 . . . . 0.0 111.37 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.8 p -82.37 -175.78 5.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 125.008 1.323 . . . . 0.0 112.942 -176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -73.93 -2.95 26.14 Favored 'General case' 0 CA--C 1.538 0.502 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 169.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.21 15.56 67.84 Favored Glycine 0 CA--C 1.528 0.868 0 O-C-N 121.043 -1.036 . . . . 0.0 112.181 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -96.27 114.32 26.0 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.463 0.705 . . . . 0.0 112.603 -167.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -162.77 178.7 38.42 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 119.929 -1.129 . . . . 0.0 112.865 167.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 mttp -98.37 171.06 8.42 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.834 0.853 . . . . 0.0 109.596 171.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.91 -178.94 50.45 Favored Glycine 0 CA--C 1.534 1.234 0 O-C-N 122.052 -0.405 . . . . 0.0 113.685 177.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -45.95 -72.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 125.259 3.973 . . . . 0.0 115.092 -166.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 5.2 mmpt? -61.35 -26.39 67.78 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -168.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -86.36 -45.36 11.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.927 0.394 . . . . 0.0 111.164 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.2 t -97.88 -35.66 10.42 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 113.226 0.825 . . . . 0.0 113.226 -166.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -104.26 -25.75 6.91 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 123.55 0.595 . . . . 0.0 113.367 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 mtt85 69.26 -51.85 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 128.476 2.711 . . . . 0.0 113.341 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.44 0 CA-C-N 117.951 0.341 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 118.369 -0.824 . . . . 0.0 109.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.17 -33.97 0.65 Allowed Glycine 0 CA--C 1.536 1.348 0 CA-C-N 119.502 1.046 . . . . 0.0 114.116 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -44.22 154.15 0.12 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 126.256 1.822 . . . . 0.0 112.93 162.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.0 m -80.52 157.52 26.1 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 121.238 -0.914 . . . . 0.0 112.62 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.8 t -82.96 62.32 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? 46.33 37.12 3.83 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 128.566 2.746 . . . . 0.0 111.572 170.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.82 -15.08 4.91 Favored Glycine 0 CA--C 1.533 1.189 0 CA-C-N 113.408 -1.723 . . . . 0.0 114.77 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.6 mmm180 -134.86 -176.68 4.32 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 120.048 1.924 . . . . 0.0 111.819 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -169.62 -179.65 0.68 Allowed Pre-proline 0 N--CA 1.447 -0.6 0 C-N-CA 128.0 2.52 . . . . 0.0 107.246 174.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -57.66 -175.88 0.07 OUTLIER 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 124.455 3.436 . . . . 0.0 116.319 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.0 m -28.98 94.98 0.01 OUTLIER 'General case' 0 C--O 1.233 0.227 0 C-N-CA 129.951 3.3 . . . . 0.0 115.767 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.78 27.77 62.17 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.196 177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.418 ' SD ' ' HE2' ' A' ' 23' ' ' LYS . 83.7 mmm -83.27 164.16 20.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 118.763 1.281 . . . . 0.0 109.454 169.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 3.4 m -140.46 164.02 31.26 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.729 0.812 . . . . 0.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.2 t -112.33 134.73 53.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.662 1.185 . . . . 0.0 112.45 -170.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.6 p -88.86 172.79 8.92 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.554 1.142 . . . . 0.0 113.218 -173.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.5 mp0 -62.02 -14.52 36.42 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 121.508 -0.745 . . . . 0.0 112.74 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.36 16.07 81.0 Favored Glycine 0 C--N 1.341 0.82 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.247 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 50.6 m -102.51 149.91 23.92 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -174.42 -161.9 25.12 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 173.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HE2' ' SD ' ' A' ' 13' ' ' MET . 66.9 mttm -122.39 171.8 8.8 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 124.447 1.099 . . . . 0.0 108.315 169.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.12 -174.53 49.35 Favored Glycine 0 CA--C 1.536 1.404 0 O-C-N 121.99 -0.444 . . . . 0.0 113.316 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -42.74 -78.77 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.55 1 C-N-CA 125.671 4.247 . . . . 0.0 116.01 -165.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -63.98 -20.19 65.71 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.742 1.155 . . . . 0.0 114.002 -167.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 94.0 m-85 -88.68 -41.38 12.63 Favored 'General case' 0 C--N 1.331 -0.221 0 O-C-N 121.707 -0.621 . . . . 0.0 111.611 174.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.9 t -100.71 -45.07 5.6 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -170.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.08 -16.14 36.45 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 119.36 -0.689 . . . . 0.0 113.527 176.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 66.73 -55.82 0.42 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 127.749 2.42 . . . . 0.0 113.422 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 118.571 0.623 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.527 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.432 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 11.4 m . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.57 -64.85 2.15 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -165.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' N ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER -80.52 163.02 24.05 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.029 0.932 . . . . 0.0 110.963 159.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 43.8 m -96.69 147.35 23.99 Favored 'General case' 0 C--O 1.235 0.291 0 O-C-N 121.258 -0.901 . . . . 0.0 110.401 165.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -78.22 75.66 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 125.798 1.639 . . . . 0.0 107.501 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.91 37.97 22.29 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 126.161 1.784 . . . . 0.0 111.075 176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.53 -13.14 30.39 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.543 1.544 . . . . 0.0 114.519 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -111.52 -171.32 1.81 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.663 1.731 . . . . 0.0 110.081 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -160.21 -178.96 0.97 Allowed Pre-proline 0 C--N 1.32 -0.692 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 160.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -63.39 150.22 89.13 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 121.624 1.616 . . . . 0.0 111.046 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.1 m -68.15 78.25 0.24 Allowed 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.99 0.916 . . . . 0.0 112.111 -169.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.17 -24.39 0.39 Allowed Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.42 1.486 . . . . 0.0 112.913 -174.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.7 mmt -86.82 172.6 9.99 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 118.799 1.299 . . . . 0.0 109.628 164.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -132.5 167.21 20.39 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.576 0.75 . . . . 0.0 110.259 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 t -124.52 137.22 54.43 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.191 0.996 . . . . 0.0 111.5 -176.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 53.1 p -90.06 151.83 21.44 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.864 0.84 . . . . 0.0 110.131 169.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -64.05 0.07 1.02 Allowed 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 114.096 1.146 . . . . 0.0 114.096 175.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 14.6 65.84 Favored Glycine 0 CA--C 1.527 0.839 0 O-C-N 121.618 -0.676 . . . . 0.0 112.869 -179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.38 152.18 51.18 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 114.336 1.236 . . . . 0.0 114.336 -168.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.51 -177.91 45.66 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 126.637 2.065 . . . . 0.0 108.51 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -96.08 -2.28 46.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 118.879 1.34 . . . . 0.0 114.019 177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.7 158.82 53.63 Favored Glycine 0 CA--C 1.535 1.287 0 O-C-N 121.987 -0.446 . . . . 0.0 112.801 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -45.36 -49.91 9.75 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 124.211 3.274 . . . . 0.0 113.646 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -71.01 -16.96 62.65 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -87.19 -36.77 17.82 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 118.783 0.72 . . . . 0.0 110.858 172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.23 -56.11 2.57 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 112.924 0.713 . . . . 0.0 112.924 -171.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -95.84 -4.36 60.35 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 121.276 -0.89 . . . . 0.0 114.116 177.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.05 -50.29 0.68 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 127.241 2.216 . . . . 0.0 112.966 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 118.008 0.367 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.18 7.32 87.03 Favored Glycine 0 CA--C 1.533 1.197 0 CA-C-O 118.82 -0.989 . . . . 0.0 114.287 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.7 mp0 -45.1 99.63 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 119.574 1.687 . . . . 0.0 113.359 173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 21' ' ' CYS . 61.7 m -69.5 163.4 25.45 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 123.241 0.616 . . . . 0.0 112.078 -177.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p -77.88 49.62 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 CA-C-O 122.652 1.215 . . . . 0.0 110.947 169.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.0 mmp_? 56.1 33.61 22.27 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 127.168 2.187 . . . . 0.0 112.592 -175.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.36 -22.04 0.35 Allowed Glycine 0 CA--C 1.531 1.077 0 CA-C-N 114.677 -1.147 . . . . 0.0 115.484 170.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.69 168.39 15.88 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.22 1.51 . . . . 0.0 113.663 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -155.16 173.1 5.15 Favored Pre-proline 0 CA--C 1.534 0.335 0 C-N-CA 126.406 1.882 . . . . 0.0 108.745 -171.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -61.15 170.09 5.42 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.626 2.217 . . . . 0.0 111.882 168.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 m 35.86 39.5 0.07 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.137 2.175 . . . . 0.0 114.754 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.48 9.98 7.19 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 126.631 2.062 . . . . 0.0 115.612 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.7 mmt -53.79 163.25 0.74 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.975 1.887 . . . . 0.0 114.422 -161.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 m -84.81 142.86 29.48 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 94.1 m -104.9 134.73 47.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.824 0.85 . . . . 0.0 109.847 172.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 81.0 p -65.04 156.81 30.23 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 155.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -79.33 -3.47 46.32 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 121.301 -0.874 . . . . 0.0 113.247 -164.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . 0.425 ' HB3' ' CD2' ' A' ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.78 50.76 4.53 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 125.369 1.461 . . . . 0.0 112.297 -178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . 0.425 ' CD2' ' HB3' ' A' ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.426 ' HB3' ' SG ' ' A' ' 4' ' ' CYS . 31.9 p -117.72 165.28 13.81 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 116.887 2.18 . . . . 0.0 116.887 -169.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 161.39 166.35 19.97 Favored Glycine 0 CA--C 1.527 0.803 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.886 166.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.2 ttpp -77.21 56.01 1.25 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.674 -0.898 . . . . 0.0 111.676 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.35 157.21 27.23 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 122.038 -0.414 . . . . 0.0 113.739 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -60.71 -43.43 32.09 Favored 'Trans proline' 0 N--CA 1.456 -0.695 0 C-N-CA 123.418 2.745 . . . . 0.0 111.648 -172.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.75 -13.79 26.52 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-O 116.8 -1.572 . . . . 0.0 114.304 176.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -98.35 -55.47 2.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 124.359 1.037 . . . . 0.0 110.103 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.4 t -80.51 -42.7 22.03 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.868 -0.52 . . . . 0.0 111.925 -168.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -89.21 -22.61 37.35 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.713 1.149 . . . . 0.0 112.742 175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.345 0.0 OUTLIER 58.53 -43.35 0.06 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 130.741 3.617 . . . . 0.0 116.251 179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 119.367 0.985 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.424 ' N ' ' OE2' ' A' ' 3' ' ' GLU . 15.7 m . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.75 14.12 7.55 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.272 0.939 . . . . 0.0 114.522 167.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' OE2' ' N ' ' A' ' 1' ' ' VAL . 56.8 mp0 -66.77 155.49 38.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.504 1.521 . . . . 0.0 112.861 -168.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.8 m -86.01 152.97 22.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 122.586 1.184 . . . . 0.0 112.852 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.47 75.93 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 171.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.73 33.1 7.81 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.637 1.575 . . . . 0.0 112.443 -178.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.36 -7.08 28.53 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.173 1.368 . . . . 0.0 115.067 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -115.81 178.84 4.16 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 119.767 1.784 . . . . 0.0 111.53 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -165.29 172.36 4.5 Favored Pre-proline 0 N--CA 1.45 -0.437 0 C-N-CA 125.636 1.574 . . . . 0.0 108.566 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.44 -176.39 2.72 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 123.577 2.851 . . . . 0.0 112.647 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.1 m 36.44 43.19 0.23 Allowed 'General case' 0 C--O 1.232 0.142 0 C-N-CA 128.699 2.8 . . . . 0.0 116.332 165.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.83 40.46 80.81 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.986 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 53.0 mtm -84.83 169.21 14.39 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 118.852 1.326 . . . . 0.0 110.895 166.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 m -122.92 163.5 20.24 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.254 1.022 . . . . 0.0 109.558 178.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -109.04 135.26 50.5 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.253 0.621 . . . . 0.0 111.649 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 42.3 t -67.06 -175.85 0.48 Allowed 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 126.615 1.966 . . . . 0.0 111.89 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.03 -18.27 27.67 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.117 166.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.97 8.47 64.91 Favored Glycine 0 CA--C 1.529 0.969 0 CA-C-O 118.83 -0.983 . . . . 0.0 115.37 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 97.1 m -102.27 155.39 18.26 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -175.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.73 -177.68 48.26 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 166.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -102.78 1.9 34.86 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 171.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.81 165.34 49.37 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 122.151 -0.343 . . . . 0.0 112.276 -177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -53.62 -51.17 11.47 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 123.627 2.885 . . . . 0.0 111.991 -172.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -62.98 -22.84 67.11 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.492 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 95.9 m-85 -85.18 -36.48 21.0 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 118.79 0.723 . . . . 0.0 111.167 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 t -105.79 -79.15 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.88 -14.29 80.2 Favored Glycine 0 CA--C 1.534 1.233 0 CA-C-N 118.868 0.758 . . . . 0.0 114.733 -172.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.256 9.7 ptp180 51.75 -26.89 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.654 1 C-N-CA 132.234 4.214 . . . . 0.0 120.032 169.896 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 120.962 1.71 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.492 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.61 71.76 1.04 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -160.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -92.5 151.26 20.28 Favored 'General case' 0 C--N 1.331 -0.237 0 O-C-N 122.056 -0.673 . . . . 0.0 110.996 -172.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.6 m -80.51 178.19 8.49 Favored 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 150.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.0 t -75.79 48.83 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.481 0 O-C-N 120.128 -1.608 . . . . 0.0 109.007 163.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.409 HH11 ' CG ' ' A' ' 6' ' ' ARG 0.259 0.0 OUTLIER 34.69 38.14 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 130.535 3.534 . . . . 0.0 113.038 -166.454 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.76 -36.74 0.07 OUTLIER Glycine 0 CA--C 1.534 1.239 0 CA-C-N 113.664 -1.607 . . . . 0.0 115.524 176.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.19 168.27 19.16 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.131 1.465 . . . . 0.0 112.894 177.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.8 t -157.05 173.98 4.48 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 126.07 1.748 . . . . 0.0 107.072 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -65.08 179.12 1.58 Allowed 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 116.102 -174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.5 m -28.96 102.99 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 129.207 3.003 . . . . 0.0 115.126 177.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.81 56.01 Favored Glycine 0 CA--C 1.531 1.07 0 CA-C-O 119.355 -0.692 . . . . 0.0 114.578 174.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.1 mmt -78.11 160.83 27.82 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 119.229 1.515 . . . . 0.0 109.719 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.0 m -138.34 165.14 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.61 0.764 . . . . 0.0 109.783 -172.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 84.1 m -119.27 124.45 46.72 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.753 0.821 . . . . 0.0 110.612 -172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.7 p -70.86 159.1 35.25 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.015 -1.074 . . . . 0.0 109.518 168.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -64.0 -7.38 8.35 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -175.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.25 8.57 74.67 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.858 1.694 . . . . 0.0 114.131 176.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.4 t -109.44 144.78 37.2 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.043 0.937 . . . . 0.0 113.215 -171.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.17 178.73 48.6 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 111.968 -0.453 . . . . 0.0 111.968 159.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 tptp -78.61 -29.5 46.06 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.57 169.64 47.39 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.331 1.443 . . . . 0.0 115.006 -159.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.4 -44.43 46.15 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.027 3.151 . . . . 0.0 112.83 -168.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.7 mmmp? -58.99 -21.75 59.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 119.457 1.026 . . . . 0.0 113.598 178.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.544 ' CE2' ' H83' ' A' ' 34' ' ' NAG . 90.5 m-85 -93.95 -46.14 7.29 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.175 0.59 . . . . 0.0 110.886 172.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.8 t -96.4 -25.89 15.54 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -163.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.34 -0.95 10.31 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.893 1.235 . . . . 0.0 113.187 172.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 68.91 -51.49 0.58 Allowed 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 128.652 2.781 . . . . 0.0 113.834 178.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 118.435 0.561 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.544 ' H83' ' CE2' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.86 -48.13 0.97 Allowed Glycine 0 CA--C 1.527 0.833 0 N-CA-C 106.85 -2.5 . . . . 0.0 106.85 -154.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -70.12 167.01 18.65 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 139.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 21.1 m -54.06 168.11 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 123.222 1.487 . . . . 0.0 112.774 174.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.1 t -79.61 53.86 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 125.145 1.378 . . . . 0.0 109.242 174.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? 48.7 36.76 8.3 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 127.443 2.297 . . . . 0.0 112.123 177.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 159.36 -24.21 0.31 Allowed Glycine 0 CA--C 1.531 1.068 0 CA-C-N 113.671 -1.604 . . . . 0.0 114.999 174.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -138.67 164.58 29.15 Favored 'General case' 0 C--O 1.224 -0.254 0 CA-C-N 119.47 1.635 . . . . 0.0 113.49 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.98 -178.45 0.85 Allowed Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 125.661 1.584 . . . . 0.0 106.816 157.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -54.72 -175.79 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 124.624 3.55 . . . . 0.0 116.51 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.9 m -30.1 94.62 0.01 OUTLIER 'General case' 0 C--O 1.234 0.258 0 C-N-CA 129.761 3.224 . . . . 0.0 115.628 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.89 27.01 66.16 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.581 -0.566 . . . . 0.0 113.586 176.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.0 mmt -76.85 171.41 14.79 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 119.045 1.422 . . . . 0.0 109.73 164.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.1 m -134.55 169.77 16.79 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.388 0.675 . . . . 0.0 109.897 164.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 11.0 m -102.58 149.74 24.11 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.044 1.338 . . . . 0.0 109.749 176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.6 p -95.63 174.64 6.88 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.442 -0.786 . . . . 0.0 111.868 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -57.08 -9.78 0.98 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 166.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 73.98 -33.17 0.91 Allowed Glycine 0 CA--C 1.53 0.97 0 O-C-N 120.619 -1.301 . . . . 0.0 114.134 179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 2.1 p -135.89 159.56 41.29 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 -167.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.33 -170.47 40.96 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 -176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.11 -4.37 21.96 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 176.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.68 164.19 53.89 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 119.727 -0.485 . . . . 0.0 112.389 -175.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -42.79 -60.01 0.84 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 124.863 3.709 . . . . 0.0 114.768 -171.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -64.93 -16.18 62.98 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -178.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.504 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 46.8 m-85 -88.2 -54.37 4.24 Favored 'General case' 0 C--O 1.227 -0.11 0 CA-C-N 118.972 0.805 . . . . 0.0 110.107 171.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -123.0 -8.48 8.31 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 114.206 1.188 . . . . 0.0 114.206 -159.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.95 60.53 2.17 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 158.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -65.44 -31.56 72.72 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.144 1.165 . . . . 0.0 114.144 -145.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 O-C-N 121.758 -0.589 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.504 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.32 58.93 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 123.428 0.537 . . . . 0.0 113.283 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mp0 -61.21 121.56 12.86 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.27 1.428 . . . . 0.0 110.841 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.1 p -76.82 167.06 22.48 Favored 'General case' 0 C--O 1.238 0.49 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -171.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -80.9 58.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 114.463 -1.244 . . . . 0.0 107.87 167.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 43.4 36.32 1.09 Allowed 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 129.454 3.102 . . . . 0.0 113.349 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.63 -10.75 4.3 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-N 113.609 -1.632 . . . . 0.0 113.774 -176.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -126.3 165.46 18.95 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 178.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 166.82 -179.23 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 130.864 3.666 . . . . 0.0 105.492 -161.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -54.96 -179.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.256 3.304 . . . . 0.0 116.873 -176.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.0 p -26.76 99.18 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 129.074 2.95 . . . . 0.0 114.581 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.2 7.57 38.99 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-O 118.73 -1.039 . . . . 0.0 115.145 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 59.6 mtt -71.1 166.61 21.05 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 119.623 1.712 . . . . 0.0 111.669 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 28' ' ' CYS . 10.5 m -126.69 174.41 8.75 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 125.566 1.547 . . . . 0.0 109.298 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.7 t -126.67 135.61 51.39 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 178.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.7 p -72.98 165.08 25.69 Favored 'General case' 0 CA--C 1.523 -0.087 0 C-N-CA 124.086 0.955 . . . . 0.0 111.817 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.4 mp0 -68.47 -12.29 61.0 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.263 -0.898 . . . . 0.0 111.966 171.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.33 15.61 56.93 Favored Glycine 0 CA--C 1.525 0.659 0 CA-C-O 117.894 -1.503 . . . . 0.0 114.657 172.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.0 m -87.82 145.08 26.26 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -175.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.13 -176.86 47.24 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 160.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -114.5 6.7 15.97 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.323 1.061 . . . . 0.0 113.184 169.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.54 177.31 54.33 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.138 0.875 . . . . 0.0 113.825 -177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -67.17 -3.7 10.3 Favored 'Trans proline' 0 C--N 1.346 0.398 1 C-N-CA 125.82 4.347 . . . . 0.0 115.667 -165.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.01 -6.44 10.95 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 117.354 -1.308 . . . . 0.0 114.217 164.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -93.51 -47.97 6.6 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 119.494 1.043 . . . . 0.0 110.904 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 14' ' ' CYS . 1.7 t -83.15 62.77 6.81 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.255 1.026 . . . . 0.0 110.891 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.15 -68.01 0.21 Allowed Glycine 0 CA--C 1.527 0.835 0 C-N-CA 126.099 1.809 . . . . 0.0 110.927 -172.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 -0.48 0.53 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.553 1.941 . . . . 0.0 113.596 170.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.298 0 O-C-N 119.995 -1.69 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 48.6 t . . . . . 0 N--CA 1.477 0.903 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.84 4.41 31.71 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.619 1.104 . . . . 0.0 113.498 -172.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.502 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 0.8 OUTLIER -77.03 149.14 35.85 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 126.294 1.838 . . . . 0.0 110.972 174.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 29.5 p -78.07 158.24 29.25 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 123.5 1.619 . . . . 0.0 113.314 -176.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.2 t -78.5 71.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 125.294 1.437 . . . . 0.0 107.883 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . 0.275 0.0 OUTLIER 42.15 36.0 0.65 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 127.475 2.31 . . . . 0.0 113.468 177.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 135.01 -21.08 3.74 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-N 114.223 -1.353 . . . . 0.0 114.721 -176.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -124.89 176.9 6.32 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.314 1.557 . . . . 0.0 113.501 -172.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.34 -174.36 0.16 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 129.361 3.064 . . . . 0.0 105.158 -178.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -52.44 -179.57 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.853 3.035 . . . . 0.0 116.576 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.3 p -37.2 106.28 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 127.547 2.339 . . . . 0.0 113.769 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.06 86.98 Favored Glycine 0 CA--C 1.529 0.963 0 CA-C-O 119.179 -0.79 . . . . 0.0 114.52 172.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 20.1 mmt -79.45 165.96 22.5 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 119.05 1.425 . . . . 0.0 111.719 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -141.59 174.84 10.18 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.865 1.266 . . . . 0.0 109.201 167.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 53.5 m -76.53 158.67 31.02 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.394 0.678 . . . . 0.0 111.175 165.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' NH2' ' A' ' 30' ' ' ARG . 28.1 p -92.31 165.44 13.09 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.232 -0.918 . . . . 0.0 110.068 156.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.6 pm0 -59.9 -1.24 0.26 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 162.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 77.86 -31.78 1.73 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 120.384 -1.448 . . . . 0.0 115.006 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . 0.405 ' HA ' ' HA ' ' A' ' 3' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -111.77 158.7 19.05 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 121.237 -0.914 . . . . 0.0 112.465 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.76 178.24 45.42 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.885 -0.51 . . . . 0.0 112.455 177.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.14 -21.19 19.82 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -177.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.5 172.21 50.38 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.055 1.312 . . . . 0.0 114.126 -167.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -39.26 -66.85 0.12 Allowed 'Trans proline' 0 N--CA 1.459 -0.537 1 C-N-CA 125.632 4.221 . . . . 0.0 115.037 -170.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -64.32 -9.34 17.12 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 26.5 m-85 -94.32 -61.15 1.57 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 166.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -130.69 0.24 4.37 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -156.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.86 -20.02 54.65 Favored Glycine 0 CA--C 1.535 1.305 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 153.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.426 ' NH2' ' HA ' ' A' ' 16' ' ' SER . 2.6 tpm_? 73.31 -37.62 0.39 Allowed 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 129.067 2.947 . . . . 0.0 115.519 160.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 118.823 0.738 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.476 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.826 0.346 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 152.52 -69.82 0.3 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 -175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.73 164.81 0.07 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.854 2.861 . . . . 0.0 116.901 170.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 75.4 m -49.18 175.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.959 2.103 . . . . 0.0 114.302 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.66 61.62 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 O-C-N 119.598 -1.939 . . . . 0.0 107.892 164.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 47.58 37.77 7.09 Favored 'General case' 0 C--O 1.224 -0.239 0 C-N-CA 129.41 3.084 . . . . 0.0 112.142 176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.78 -13.89 7.63 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 126.204 1.859 . . . . 0.0 113.85 -178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.0 mmm180 -118.51 -179.48 3.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.223 1.512 . . . . 0.0 111.698 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -168.9 -178.83 0.63 Allowed Pre-proline 0 N--CA 1.449 -0.499 0 C-N-CA 126.642 1.977 . . . . 0.0 107.703 169.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -57.22 -179.79 0.11 Allowed 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 124.478 3.452 . . . . 0.0 115.629 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.5 m -12.73 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.1 0 C-N-CA 129.987 3.315 . . . . 0.0 116.196 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.11 6.28 38.09 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 118.607 -1.107 . . . . 0.0 115.42 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -73.39 168.32 19.45 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 120.116 1.958 . . . . 0.0 111.456 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.7 m -126.32 166.55 16.93 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.72 1.208 . . . . 0.0 109.551 -175.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.2 t -116.79 131.5 56.94 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.516 0.726 . . . . 0.0 110.984 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 80.7 p -83.87 161.56 20.83 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 124.717 1.207 . . . . 0.0 112.689 -171.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -70.05 -1.92 11.29 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 121.468 -0.77 . . . . 0.0 112.487 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.18 3.51 79.01 Favored Glycine 0 CA--C 1.528 0.858 0 CA-C-O 118.739 -1.034 . . . . 0.0 114.609 174.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -120.49 149.03 43.05 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -175.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.8 -171.73 44.73 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -116.67 0.06 12.51 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.67 167.3 54.82 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 121.718 -0.614 . . . . 0.0 112.622 -178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -54.09 -30.93 62.53 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 124.18 3.253 . . . . 0.0 114.378 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -78.25 -10.38 59.63 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.03 -1.044 . . . . 0.0 113.767 175.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.603 ' CE1' ' H83' ' A' ' 34' ' ' NAG . 72.4 m-85 -109.44 -51.12 2.91 Favored 'General case' 0 C--O 1.225 -0.221 0 CA-C-N 118.806 0.73 . . . . 0.0 111.974 176.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 t -85.22 65.57 9.28 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 122.398 1.094 . . . . 0.0 112.395 -163.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.8 -70.64 0.56 Allowed Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.59 5.03 0.51 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 158.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.385 0 O-C-N 119.997 -1.689 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.603 ' H83' ' CE1' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.41 22.5 4.07 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.844 1.211 . . . . 0.0 113.541 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mp0 -80.02 167.56 20.28 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.039 1.736 . . . . 0.0 112.206 -168.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.1 m -110.48 156.78 20.37 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 123.191 1.472 . . . . 0.0 112.556 172.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -76.6 76.07 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 125.856 1.662 . . . . 0.0 107.985 177.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 47.62 34.33 3.56 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.89 1.676 . . . . 0.0 113.009 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.24 -11.93 5.28 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-O 117.955 -1.47 . . . . 0.0 116.061 173.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -126.84 155.45 42.89 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 120.762 2.281 . . . . 0.0 112.897 173.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 11.1 t -117.29 169.52 7.31 Favored Pre-proline 0 C--O 1.24 0.568 0 C-N-CA 126.036 1.734 . . . . 0.0 106.664 170.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -67.05 174.32 7.09 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.6 1.533 . . . . 0.0 111.545 165.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t 57.38 -172.59 0.09 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 116.001 1.852 . . . . 0.0 116.001 167.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.05 42.73 0.62 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.845 1.688 . . . . 0.0 113.645 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 24.5 mmt -103.76 171.92 7.09 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.798 1.239 . . . . 0.0 110.668 176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.0 m -129.62 169.87 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.902 1.281 . . . . 0.0 109.135 172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 69.6 m -125.66 146.11 49.87 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.367 0.667 . . . . 0.0 112.418 -175.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 59.8 p -96.47 159.58 14.87 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 124.075 0.95 . . . . 0.0 112.454 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 -64.1 -14.15 52.66 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.228 -0.92 . . . . 0.0 112.327 169.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.73 7.33 63.07 Favored Glycine 0 C--N 1.339 0.717 0 CA-C-O 118.287 -1.285 . . . . 0.0 113.846 174.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.2 t -108.58 142.42 39.04 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 125.345 1.458 . . . . 0.0 112.872 -171.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.9 167.63 36.24 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 112.146 -0.382 . . . . 0.0 112.146 162.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -102.58 60.18 0.81 Allowed 'General case' 0 N--CA 1.467 0.39 0 O-C-N 121.489 -1.006 . . . . 0.0 109.784 172.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -150.13 167.4 30.08 Favored Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.89 -0.484 . . . . 0.0 111.89 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -42.65 -59.01 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 125.012 3.808 . . . . 0.0 114.193 -168.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -71.58 -13.12 61.68 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -93.11 -34.9 13.47 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 118.307 0.503 . . . . 0.0 111.245 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 t -101.21 -52.3 3.3 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -173.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.77 -5.05 56.76 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 123.901 0.763 . . . . 0.0 114.195 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.67 -50.94 0.67 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 127.428 2.291 . . . . 0.0 113.1 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.486 0 O-C-N 121.924 -0.485 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.53 -71.75 1.04 Allowed Glycine 0 CA--C 1.526 0.739 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -168.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 38.86 169.64 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 131.377 3.871 . . . . 0.0 118.024 176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.5 m -41.54 174.13 0.0 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.597 1.959 . . . . 0.0 115.052 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 38.7 t -77.28 63.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 O-C-N 118.917 -2.365 . . . . 0.0 107.875 164.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.07 42.32 4.77 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 129.857 3.263 . . . . 0.0 111.145 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.14 -5.19 25.36 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.786 2.136 . . . . 0.0 115.294 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.14 177.69 4.68 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.574 1.687 . . . . 0.0 108.615 168.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.2 167.54 12.81 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 160.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.05 167.47 26.93 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.607 2.204 . . . . 0.0 111.188 176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.2 t 53.88 -168.46 0.06 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.242 1.02 . . . . 0.0 112.718 -173.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.27 24.95 0.16 Allowed Glycine 0 CA--C 1.538 1.513 0 C-N-CA 124.47 1.034 . . . . 0.0 115.017 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.7 mmt -88.43 163.34 16.02 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.306 1.553 . . . . 0.0 111.016 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -135.44 153.49 51.76 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.4 t -102.29 162.01 13.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.653 0.781 . . . . 0.0 111.334 -174.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.0 p -117.25 169.12 9.72 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.857 0.863 . . . . 0.0 112.592 173.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.2 mt-30 -56.52 -13.71 2.55 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.5 12.38 82.34 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.607 -0.683 . . . . 0.0 112.282 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 20.8 p -139.52 166.16 25.32 Favored 'General case' 0 C--N 1.335 -0.059 0 O-C-N 121.624 -0.673 . . . . 0.0 112.758 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.36 -179.39 43.96 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 177.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -72.97 -33.6 65.95 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -82.23 165.2 44.74 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.923 -1.035 . . . . 0.0 115.198 -154.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -49.81 -38.64 47.71 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 124.449 3.432 . . . . 0.0 114.182 -177.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -61.64 -19.49 62.34 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 114.298 1.221 . . . . 0.0 114.298 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -97.94 -62.12 1.29 Allowed 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 166.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -79.02 -16.23 57.15 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 -158.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -120.19 17.43 9.81 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.899 1.238 . . . . 0.0 110.841 163.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 45.2 tpt85 60.68 -23.72 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 128.128 2.571 . . . . 0.0 116.662 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.478 0 O-C-N 119.859 -1.776 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.2 t . . . . . 0 N--CA 1.476 0.836 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 132.06 -46.39 1.07 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 -159.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -63.54 149.32 46.53 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 139.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -71.59 154.05 41.7 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 120.855 -1.153 . . . . 0.0 112.482 -167.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.1 t -81.37 63.45 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 C-N-CA 125.146 1.379 . . . . 0.0 107.547 175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.23 37.44 8.31 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 127.652 2.381 . . . . 0.0 112.074 168.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 129.83 -13.75 5.8 Favored Glycine 0 CA--C 1.534 1.249 0 CA-C-N 113.629 -1.623 . . . . 0.0 114.483 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.2 mmm180 -130.76 -174.71 3.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 119.642 1.721 . . . . 0.0 111.167 178.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -153.19 -176.58 0.61 Allowed Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 152.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -53.02 177.63 0.06 OUTLIER 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.805 3.003 . . . . 0.0 116.622 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.0 p -44.88 112.25 0.41 Allowed 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 127.236 2.214 . . . . 0.0 112.689 -179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.68 1.62 87.3 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 119.207 -0.774 . . . . 0.0 114.118 174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.9 mtt -87.62 167.33 14.0 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 119.321 1.561 . . . . 0.0 112.221 174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -128.14 165.06 21.14 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 124.491 1.117 . . . . 0.0 108.739 162.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.4 t -89.6 164.57 14.7 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.836 0.855 . . . . 0.0 109.415 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.9 p -126.56 171.84 10.76 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 122.412 1.101 . . . . 0.0 112.816 179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.58 -11.07 0.5 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 126.237 1.815 . . . . 0.0 114.344 168.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.91 17.16 75.15 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 118.954 0.797 . . . . 0.0 111.522 -167.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 10.6 p -133.65 160.53 37.26 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 171.78 38.25 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.763 176.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 55.97 3.46 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -171.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.48 174.34 43.77 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 119.754 -1.213 . . . . 0.0 115.287 170.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -51.08 -29.66 28.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 125.072 3.848 . . . . 0.0 114.752 -175.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -34.54 26.72 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 117.835 -1.079 . . . . 0.0 112.868 173.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.03 -55.54 2.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 O-C-N 126.508 2.38 . . . . 0.0 108.517 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.1 t -67.77 -19.39 65.1 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.098 0.959 . . . . 0.0 113.406 -164.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -130.23 25.31 4.34 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.277 0.941 . . . . 0.0 111.053 167.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER 41.95 29.04 0.11 Allowed 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.855 2.062 . . . . 0.0 115.108 -168.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 O-C-N 120.758 -1.214 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.2 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 119.528 -0.272 . . . . 0.0 110.729 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.99 22.78 34.62 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 123.701 0.667 . . . . 0.0 112.288 -174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.7 pm0 -80.53 146.23 31.41 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.328 1.451 . . . . 0.0 111.362 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.6 m -79.76 151.34 30.42 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 122.861 1.315 . . . . 0.0 113.182 -163.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.9 t -70.84 81.8 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 125.158 1.383 . . . . 0.0 107.418 167.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 50.81 33.38 8.45 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.892 1.677 . . . . 0.0 112.54 176.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 114.34 -2.52 23.7 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.412 -1.267 . . . . 0.0 115.462 178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 mmm180 -129.48 168.59 16.12 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 120.662 2.231 . . . . 0.0 113.127 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.5 m -129.57 178.63 1.6 Allowed Pre-proline 0 C--O 1.24 0.593 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 153.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -48.86 178.9 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 124.041 3.16 . . . . 0.0 113.381 163.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -61.27 174.69 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 122.921 1.343 . . . . 0.0 113.892 -172.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 65.45 -16.79 0.18 Allowed Glycine 0 CA--C 1.538 1.475 0 CA-C-O 118.215 -1.325 . . . . 0.0 116.345 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 52.8 mtt -103.78 166.12 10.61 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 120.287 2.043 . . . . 0.0 112.174 175.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 10.2 m -133.17 157.19 45.98 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.519 0.727 . . . . 0.0 110.369 169.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.5 t -96.61 134.83 39.34 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 118.058 0.39 . . . . 0.0 111.2 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 55.2 p -86.79 167.48 14.36 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 124.023 0.929 . . . . 0.0 112.857 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.61 -2.58 3.61 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.24 18.99 59.7 Favored Glycine 0 C--N 1.339 0.696 0 CA-C-O 119.014 -0.881 . . . . 0.0 113.713 174.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.3 m -95.11 127.67 41.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.438 0.695 . . . . 0.0 111.239 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.27 -151.67 7.59 Favored Glycine 0 CA--C 1.524 0.622 0 O-C-N 121.633 -0.667 . . . . 0.0 112.535 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -124.46 176.31 6.58 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.823 1.649 . . . . 0.0 111.94 -167.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.3 -179.2 7.46 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 124.527 1.061 . . . . 0.0 113.974 170.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -51.98 -46.91 29.39 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.189 2.593 . . . . 0.0 112.346 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -60.61 -38.19 83.9 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -170.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.811 ' CE1' ' H83' ' A' ' 34' ' ' NAG . 9.6 m-85 -91.37 -50.34 5.86 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 119.109 0.868 . . . . 0.0 110.418 171.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.8 t -87.73 -36.58 17.27 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -164.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -32.88 58.44 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 171.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 64.3 -27.71 0.09 Allowed 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 130.147 3.379 . . . . 0.0 116.526 163.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 119.948 1.249 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.811 ' H83' ' CE1' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 18.1 m . . . . . 0 N--CA 1.477 0.904 0 CA-C-O 119.303 -0.379 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.65 12.49 11.51 Favored Glycine 0 CA--C 1.538 1.485 0 C-N-CA 126.128 1.823 . . . . 0.0 114.138 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -68.02 111.22 4.3 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 128.226 2.61 . . . . 0.0 111.0 -166.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 23.5 p -57.42 173.04 0.28 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 -166.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.6 t -81.95 48.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 O-C-N 121.086 -1.009 . . . . 0.0 110.368 -172.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.71 47.6 6.18 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 128.193 2.597 . . . . 0.0 110.278 176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.6 -0.13 26.17 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 126.014 1.769 . . . . 0.0 114.031 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.3 mtm-85 -135.61 167.57 20.87 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 125.162 1.385 . . . . 0.0 109.054 -176.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 70.2 m -144.24 161.18 46.08 Favored Pre-proline 0 N--CA 1.45 -0.432 0 C-N-CA 123.818 0.847 . . . . 0.0 110.125 -177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.47 161.8 34.03 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.338 2.025 . . . . 0.0 110.378 166.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.4 t 52.1 -170.41 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 122.593 1.187 . . . . 0.0 113.155 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.04 24.4 0.25 Allowed Glycine 0 CA--C 1.538 1.475 0 O-C-N 120.928 -1.107 . . . . 0.0 114.853 178.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 74.2 mtm -88.79 170.21 10.96 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 119.347 1.573 . . . . 0.0 111.905 -174.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 m -129.5 161.29 30.77 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.992 0.917 . . . . 0.0 108.975 -178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.7 t -100.65 125.45 47.06 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 118.006 0.366 . . . . 0.0 111.469 177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.4 p -65.82 159.44 25.32 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 122.155 0.979 . . . . 0.0 111.39 173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.9 mp0 -85.66 5.66 30.99 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 121.465 -0.772 . . . . 0.0 110.871 177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.64 11.21 31.34 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.656 -1.08 . . . . 0.0 115.389 171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -87.46 139.36 30.62 Favored 'General case' 0 N--CA 1.467 0.392 0 O-C-N 120.907 -1.121 . . . . 0.0 112.723 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -172.09 173.18 45.13 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.684 -0.566 . . . . 0.0 111.684 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.475 ' HE3' ' HA ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -91.71 -13.57 31.47 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 178.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.1 160.39 51.27 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.212 0.434 . . . . 0.0 113.111 -171.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -58.66 -36.39 97.28 Favored 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.055 2.504 . . . . 0.0 111.862 -175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.1 mtpt -56.39 -33.09 65.43 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 123.671 0.788 . . . . 0.0 112.494 174.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -81.94 -52.63 6.88 Favored 'General case' 0 CA--C 1.518 -0.273 0 C-N-CA 123.026 0.53 . . . . 0.0 109.966 175.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.2 t -83.68 63.04 7.22 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-O 122.221 1.01 . . . . 0.0 111.76 -164.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.04 -27.54 1.15 Allowed Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.603 1.573 . . . . 0.0 114.381 170.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 73.92 -48.07 0.66 Allowed 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 128.913 2.885 . . . . 0.0 112.211 176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.393 0 O-C-N 122.103 -0.373 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 108.12 45.17 1.11 Allowed Glycine 0 CA--C 1.525 0.691 0 C-N-CA 124.327 0.965 . . . . 0.0 111.511 -169.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.15 150.68 29.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 122.884 1.326 . . . . 0.0 114.498 -158.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 34.5 m -88.86 163.25 15.72 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.827 -1.078 . . . . 0.0 112.956 -155.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.47 53.57 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 125.086 1.354 . . . . 0.0 109.09 165.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? 53.22 35.69 20.63 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 127.825 2.45 . . . . 0.0 112.658 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 168.24 -27.37 0.14 Allowed Glycine 0 CA--C 1.53 1.03 0 CA-C-N 114.171 -1.377 . . . . 0.0 115.087 173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -137.95 149.55 46.26 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 119.004 1.402 . . . . 0.0 112.509 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.56 173.27 4.47 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 158.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -71.74 173.99 11.8 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.225 1.95 . . . . 0.0 110.957 164.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.6 t 57.74 -174.46 0.08 Allowed 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 168.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.87 16.35 0.22 Allowed Glycine 0 CA--C 1.536 1.364 0 C-N-CA 125.923 1.725 . . . . 0.0 115.636 -177.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.3 mmt -85.32 175.6 8.81 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 118.859 1.33 . . . . 0.0 110.411 174.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -134.05 167.85 19.89 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.956 0.902 . . . . 0.0 109.829 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.1 t -133.87 135.26 43.57 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 -166.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.7 p -81.93 168.43 17.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.565 -0.71 . . . . 0.0 111.599 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pm0 -72.59 -13.61 61.43 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 120.308 -1.495 . . . . 0.0 113.408 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.54 30.77 57.76 Favored Glycine 0 CA--C 1.524 0.596 0 O-C-N 120.721 -1.237 . . . . 0.0 112.663 178.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PFF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 15.5 t -107.7 147.53 30.62 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -169.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.09 -170.42 43.29 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 173.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -118.3 1.46 11.85 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.443 1.275 . . . . 0.0 114.443 169.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -72.02 173.16 45.69 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.862 0.744 . . . . 0.0 112.629 175.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -52.54 -53.61 6.58 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 124.264 3.309 . . . . 0.0 114.09 -163.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.453 ' HB3' ' H81' ' A' ' 34' ' ' NAG . 1.7 mmmm -74.36 -6.35 47.58 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.49 ' CZ ' ' H83' ' A' ' 34' ' ' NAG . 52.0 m-85 -95.12 -42.54 8.54 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 119.36 0.982 . . . . 0.0 109.86 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -107.36 10.06 29.72 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -173.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 61.29 37.92 94.83 Favored Glycine 0 CA--C 1.527 0.782 0 O-C-N 120.795 -1.191 . . . . 0.0 110.844 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 65.95 -4.74 0.6 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.274 1.829 . . . . 0.0 114.342 -168.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.339 0 O-C-N 119.929 -1.732 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' NAG . . . . . 0.49 ' H83' ' CZ ' ' A' ' 27' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_